Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine

• Ngā kaituhi matua: Rodolphe H. Lebeau (Author), Indira Mendez-David (Author), Laura Kucynski-Noyau (Author), Céline Henry (Author), David Attali (Author), Marion Plaze (Author), Romain Colle (Author), Emmanuelle Corruble (Author), Alain M. Gardier (Author), Raphaël Gaillard (Author), Jean-Philippe Guilloux (Author), Denis J. David (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Major depressive disorder (MDD) is the psychiatric disorder with the highest prevalence in the world. Pharmacological antidepressant treatment (AD), such as selective serotonin reuptake inhibitors [SSRI, i.e., fluoxetine (Flx)] is the first line of treatment for MDD. Despite its efficacy, lack of AD...